Back
Akari Therapeutics PLC Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
AKTX
Akari Therapeutics PLC
Last Price:
1.30
Seasonality Move:
-10.36%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Sell |
| 20-day SMA: | 2.18 | Sell |
| 50-day SMA: | 2.57 | Sell |
| 200-day SMA: | 2.53 | Sell |
| 8-day EMA: | 1.7 | Sell |
| 20-day EMA: | 2.05 | Sell |
| 50-day EMA: | 2.47 | Sell |
| 200-day EMA: | 2.91 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 26.66 | Sell |
| Chaikin Money Flow: | 110616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.57) | Sell |
| Bollinger Bands (100): | (2.43 - 3.73) | Sell |
Akari Therapeutics PLC Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 1.30 while AKTX 8-day simple moving average is 1.80, which is a Sell signal.
- The stock price of AKTX is 1.30 while Akari Therapeutics PLC 20-day SMA is 2.18, which makes it a Sell.
- Akari Therapeutics PLC 50-day simple moving average is 2.57 while AKTX share price is 1.30, making it a Sell technically.
- AKTX stock price is 1.30 and Akari Therapeutics PLC 200-day simple moving average is 2.53, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Sell
The current Akari Therapeutics PLC [AKTX] share price is $1.30. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
32.19M
Price in USD:
1.30
Share Volume:
142.22K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
1.08
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?
The Akari Therapeutics PLC stock price is 1.30 USD today. -
Will AKTX stock go up or go down?
Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Akari Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 1.30 while AKTX 8-day exponential moving average is 1.70, which is a Sell signal.
- The stock price of AKTX is 1.30 while Akari Therapeutics PLC 20-day EMA is 2.05, which makes it a Sell.
- Akari Therapeutics PLC 50-day exponential moving average is 2.47 while AKTX share price is 1.30, making it a Sell technically.
- AKTX stock price is 1.30 and Akari Therapeutics PLC 200-day simple moving average is 2.91, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
- AKTX Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Akari Therapeutics PLC is a Sell
- Akari Therapeutics PLC Relative Strength Index (RSI) is 26.66, which suggest Akari Therapeutics PLC is oversold
- The Bollinger Bands (25) for Akari Therapeutics PLC is (1.81 - 2.57), which suggest Akari Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Akari Therapeutics PLC is (2.43 - 3.73), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.